stanley-choy-150pxHarry H. Penner, Jr., J.D.

Harry Penner is Co-Founder and Executive Chairman of New Haven Pharmaceuticals and has 30+ years of management experience in the pharmaceutical and biotechnology sectors. He has previously co-founded seven other biotechnology companies, including Rib-X Pharmaceuticals, Marinus Pharmaceuticals, Affinimark Technologies, Prevention Pharmaceuticals, RxGen, MAKScientific, and RHEI Pharmaceuticals. From 1993 to 2001, he was President, Chief Executive Officer and Vice Chairman of Neurogen Corporation, a publicly-traded biotechnology company, and from 1985 to 1993, he was Executive Vice President of Novo Nordisk A/S in Denmark and the US. He has also been Chair of the Connecticut Technology Council and Chair of the Connecticut Board of Governors of Higher Education.